Role of Nepafenac in Reducing Macular Volume After Epiretinal Membrane Surgery

Summary

The purpose of this study is to compare the macular volume of patients treated with a 3-month course of topical Nepafenac (0.1% solution) to patients treated with a placebo course following epiretinal membrane surgery.

Timeline

Start

2009-01

Primary completion

2010-06

Completion

2010-06

Publications

• Schoenberger SD, Miller DM, Petersen MR, Foster RE, Riemann CD, Sisk RA. Nepafenac for epiretinal membrane surgery. Ophthalmology. 2011 Jul;118(7):1482.e1-3. doi: 10.1016/j.ophtha.2011.01.034. No abstract available.

Drugs

Indications